748 related articles for article (PubMed ID: 17161895)
21. Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents.
Bajgar J; Kuca K; Jun D; Bartosova L; Fusek J
Curr Drug Metab; 2007 Dec; 8(8):803-9. PubMed ID: 18220560
[TBL] [Abstract][Full Text] [Related]
22. Assessment of neuromuscular dysfunction during poisoning by organophosphorus compounds.
Thiermann H; Seeger T; Gonder S; Herkert N; Antkowiak B; Zilker T; Eyer F; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):265-9. PubMed ID: 20036651
[TBL] [Abstract][Full Text] [Related]
23. [Use of oximes in the therapy of acute intoxication by organophosphorus compounds].
Raszewski G; Filip R
Przegl Lek; 2004; 61(3):181-4. PubMed ID: 15518329
[TBL] [Abstract][Full Text] [Related]
24. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning.
Lundy PM; Hamilton MG; Sawyer TW; Mikler J
Toxicology; 2011 Jul; 285(3):90-6. PubMed ID: 21524678
[TBL] [Abstract][Full Text] [Related]
25. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
26. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning.
Dorandeu F; Mikler JR; Thiermann H; Tenn C; Davidson C; Sawyer TW; Lallement G; Worek F
Toxicology; 2007 Apr; 233(1-3):128-44. PubMed ID: 17092624
[TBL] [Abstract][Full Text] [Related]
27. Organophosphates and their impact on the global environment.
Satoh T; Hosokawa M
Neurotoxicology; 2000; 21(1-2):223-7. PubMed ID: 10794404
[TBL] [Abstract][Full Text] [Related]
28. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
Kalisiak J; Ralph EC; Cashman JR
J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
[TBL] [Abstract][Full Text] [Related]
29. New experimental Oximes in the management of organophosphorus pesticides poisoning.
Barelli A; Soave PM; Del Vicario M; Barelli R
Minerva Anestesiol; 2011 Dec; 77(12):1197-203. PubMed ID: 21799476
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of medical countermeasures against organophosphorus compounds: the value of experimental data and computer simulations.
Worek F; Aurbek N; Herkert NM; John H; Eddleston M; Eyer P; Thiermann H
Chem Biol Interact; 2010 Sep; 187(1-3):259-64. PubMed ID: 19917271
[TBL] [Abstract][Full Text] [Related]
31. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides.
Musilek K; Dolezal M; Gunn-Moore F; Kuca K
Med Res Rev; 2011 Jul; 31(4):548-75. PubMed ID: 20027669
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication.
Husain K; Ansari RA; Ferder L
Indian J Exp Biol; 2010 Jul; 48(7):642-50. PubMed ID: 20929049
[TBL] [Abstract][Full Text] [Related]
33. Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach.
Worek F; Szinicz L; Thiermann H
Chem Biol Interact; 2005 Dec; 157-158():349-52. PubMed ID: 16266695
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients.
Thiermann H; Zilker T; Eyer F; Felgenhauer N; Eyer P; Worek F
Toxicol Lett; 2009 Dec; 191(2-3):297-304. PubMed ID: 19793545
[TBL] [Abstract][Full Text] [Related]
35. Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compounds.
Bierwisch A; Wille T; Thiermann H; Worek F
Toxicol Lett; 2016 Mar; 246():49-56. PubMed ID: 26851641
[TBL] [Abstract][Full Text] [Related]
36. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
Jokanović M; Stojiljković MP
Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
[TBL] [Abstract][Full Text] [Related]
37. Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.
Cadieux CL; Broomfield CA; Kirkpatrick MG; Kazanski ME; Lenz DE; Cerasoli DM
Chem Biol Interact; 2010 Sep; 187(1-3):229-33. PubMed ID: 20433814
[TBL] [Abstract][Full Text] [Related]
38. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and clinical profile after organophosphorus poisoning--a placebo-controlled trial using pralidoxime.
Cherian MA; Roshini C; Visalakshi J; Jeyaseelan L; Cherian AM
J Assoc Physicians India; 2005 May; 53():427-31. PubMed ID: 16124349
[TBL] [Abstract][Full Text] [Related]
40. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
